Clinical trial
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
NCT00094887 · Mallinckrodt, Industry · Completed
Key facts
| NCT number | NCT00094887 |
|---|---|
| Title | Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises |
| Official title | A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis |
| Lead sponsor | Mallinckrodt, Industry |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell |
| Intervention type | Drug |
| Interventions | Nitric Oxide, Placebo |
| Enrollment | 150 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Oct 28, 2004 |
| Last update posted | Feb 5, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: